Precision epilepsy medications mark a major shift in treatment, moving away from generalized therapy toward personalized care. By identifying specific genetic mutations, molecular pathways, and patient characteristics, clinicians can tailor drug selection to maximize efficacy while minimizing side effects. This approach not only improves seizure control in hard-to-treat cases but also reduces the trial-and-error burden for patients and families. As research advances, precision medicine promises to make epilepsy treatment more targeted, predictable, and effective. In this context, renowned pediatric neurologist Dr.
Vykuntaraju K. Gowda will share cutting-edge insights on precision epilepsy medications, offering practical takeaways and a forward-looking perspective during our session on October 6 , 2025 , at 3:00 PM IST . Do Not Miss This Session! Suggested readings Cutting-Edge Brain…
